Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria-An approach using statistical modelling.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lakshminarayan R,Ranganath

第一单位： Departments of Clinical Biochemistry and Metabolic Medicine Liverpool University Hospitals NHS Foundation Trusts Liverpool UK.

作者： Lakshminarayan R,Ranganath ^[1] ; Anna M,Milan ^[2] ; Andrew T,Hughes ^[1] ; Milad,Khedr ^[2] ; Brendan P,Norman ^[1] ; Mohammed,Alsbou ^[2] ; Richard,Imrich ^[1] ; Matthew,Gornall ^[2] ; Nicolas,Sireau ^[3] ; James A,Gallagher ^[4] ; Richard,Jackson ^[5]

作者单位： Departments of Clinical Biochemistry and Metabolic Medicine Liverpool University Hospitals NHS Foundation Trusts Liverpool UK. ^[1] Musculoskeletal Biology and Ageing University of Liverpool, William Henry Duncan Building Liverpool UK. ^[2] Faculty of Medicine Mutah University Karak Jordan. ^[3] National Institute of Rheumatic Diseases Piešťany Slovakia. ^[4] Biomedical Research Center, Slovak Academy of Sciences Bratislava Slovakia. ^[5] Liverpool Cancer Trials Unit University of Liverpool Liverpool UK. ^[6] AKU Society Cambridge UK. ^[7]

关键词 AKUSSI alkaptonuria disease progression homogentisic acid nitisinone safety slope analysis

DOI 10.1002/jmd2.12261

PMID 35028273

发布时间 2024-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交